Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Soleimani, Laili
Welch, Alison
and
Murrough, James W.
2015.
“Does Ketamine Have Rapid Anti-Suicidal Ideation Effects?”.
Current Treatment Options in Psychiatry,
Vol. 2,
Issue. 4,
p.
383.
Averill, Lynnette A.
Murrough, James W.
and
Abdallah, Chadi G.
2016.
Ketamine for Treatment-Resistant Depression.
p.
99.
Mallick, Faryal
and
McCullumsmith, Cheryl B.
2016.
Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.
Current Psychiatry Reports,
Vol. 18,
Issue. 6,
Schwartz, Jaclyn
Murrough, James W
and
Iosifescu, Dan V
2016.
Ketamine for treatment-resistant depression: recent developments and clinical applications: Table 1.
Evidence Based Mental Health,
Vol. 19,
Issue. 2,
p.
35.
Xu, Ying
Hackett, Maree
Carter, Gregory
Loo, Colleen
Gálvez, Verònica
Glozier, Nick
Glue, Paul
Lapidus, Kyle
McGirr, Alexander
Somogyi, Andrew A.
Mitchell, Philip B.
and
Rodgers, Anthony
2016.
Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.
International Journal of Neuropsychopharmacology,
Vol. 19,
Issue. 4,
p.
pyv124.
Pešić, Vesna
Petrović, Jelena
and
M Jukić, Marin
2016.
Molecular Mechanism and Clinical Relevance of Ketamine as Rapid‐Acting Antidepressant.
Drug Development Research,
Vol. 77,
Issue. 7,
p.
414.
Giner, Lucas
Blasco-Fontecilla, Hilario
De La Vega, Diego
and
Courtet, Philippe
2016.
Cognitive, Emotional, Temperament, and Personality Trait Correlates of Suicidal Behavior.
Current Psychiatry Reports,
Vol. 18,
Issue. 11,
Ballard, Elizabeth D.
and
Price, Rebecca B.
2016.
Ketamine for Treatment-Resistant Depression.
p.
43.
Pałucha-Poniewiera, Agnieszka
and
Pilc, Andrzej
2016.
Glutamate-Based Drug Discovery for Novel Antidepressants.
Expert Opinion on Drug Discovery,
Vol. 11,
Issue. 9,
p.
873.
Bobo, William V.
Vande Voort, Jennifer L.
Croarkin, Paul E.
Leung, Jonathan G.
Tye, Susannah J.
and
Frye, Mark A.
2016.
KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.
Depression and Anxiety,
Vol. 33,
Issue. 8,
p.
698.
Jiang, Min
Wang, Mao-Hua
Wang, Xiao-Bin
Liu, Li
Wu, Jia-Li
Yang, Xiao-Lin
Liu, Xue-Ru
and
Zhang, Chun-Xiang
2016.
Effect of intraoperative application of ketamine on postoperative depressed mood in patients undergoing elective orthopedic surgery.
Journal of Anesthesia,
Vol. 30,
Issue. 2,
p.
232.
Wilkinson, Samuel T.
and
Sanacora, Gerard
2016.
KETAMINE: A POTENTIAL RAPID-ACTING ANTISUICIDAL AGENT?.
Depression and Anxiety,
Vol. 33,
Issue. 8,
p.
711.
Kim, Jae-Min
Kang, Hee-Ju
Bae, Kyung-Yeol
Kim, Sung-Wan
Shin, Il-Seon
Hong, Young Joon
Ahn, Youngkeun
Jeong, Myung Ho
Kang, Hyuno
and
Yoon, Jin-Sang
2016.
Determinants and escitalopram treatment effects on suicidal ideation in patients with acute coronary syndrome: Findings from the K-DEPACS and EsDEPACS studies.
International Journal of Cardiology,
Vol. 219,
Issue. ,
p.
225.
Malhi, Gin S.
Byrow, Yulisha
Cassidy, Frederick
Cipriani, Andrea
Demyttenaere, Koen
Frye, Mark A.
Gitlin, Michael
Kennedy, Sidney H.
Ketter, Terence A.
Lam, Raymond W.
McShane, Rupert
Mitchell, Alex J.
Ostacher, Michael J.
Rizvi, Sakina J.
Thase, Michael E.
and
Tohen, Mauricio
2016.
Ketamine: stimulating antidepressant treatment?.
BJPsych Open,
Vol. 2,
Issue. 3,
p.
e5.
Li, Linda
and
Vlisides, Phillip E.
2016.
Ketamine: 50 Years of Modulating the Mind.
Frontiers in Human Neuroscience,
Vol. 10,
Issue. ,
Lee, Yena
Syeda, Kahlood
Maruschak, Nadia A.
Cha, Danielle S.
Mansur, Rodrigo B.
Wium-Andersen, Ida K.
Woldeyohannes, Hanna O.
Rosenblat, Joshua D.
and
McIntyre, Roger S.
2016.
A New Perspective on the Anti-Suicide Effects With Ketamine Treatment.
Journal of Clinical Psychopharmacology,
Vol. 36,
Issue. 1,
p.
50.
Grunebaum, Michael F.
Ellis, Steven P.
Keilp, John G.
Moitra, Vivek K.
Cooper, Thomas B.
Marver, Julia E.
Burke, Ainsley K.
Milak, Matthew S.
Sublette, M. Elizabeth
Oquendo, Maria A.
and
Mann, J. John
2017.
Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam‐controlled randomized clinical trial.
Bipolar Disorders,
Vol. 19,
Issue. 3,
p.
176.
Kang, Hee-Ju
Bae, Kyung-Yeol
Kim, Sung-Wan
Shin, Il-Seon
Hong, Young Joon
Ahn, Youngkeun
Jeong, Myung Ho
Yoon, Jin-Sang
and
Kim, Jae-Min
2017.
Genetic predisposition toward suicidal ideation in patients with acute coronary syndrome.
Oncotarget,
Vol. 8,
Issue. 55,
p.
94951.
Gould, T D
Georgiou, P
Brenner, L A
Brundin, L
Can, A
Courtet, P
Donaldson, Z R
Dwivedi, Y
Guillaume, S
Gottesman, I I
Kanekar, S
Lowry, C A
Renshaw, P F
Rujescu, D
Smith, E G
Turecki, G
Zanos, P
Zarate, C A
Zunszain, P A
and
Postolache, T T
2017.
Animal models to improve our understanding and treatment of suicidal behavior.
Translational Psychiatry,
Vol. 7,
Issue. 4,
p.
e1092.
Patel, Kinjal
Abdool, Petal S.
Rajji, Tarek K.
and
Mulsant, Benoit H.
2017.
Pharmacotherapy of major depression in late life: what is the role of new agents?.
Expert Opinion on Pharmacotherapy,
Vol. 18,
Issue. 6,
p.
599.